Feature | Cardiovascular Ultrasound | July 07, 2015

ASE: Echocardiography Can Provide More Complete Picture of Hypertension

Joint document offers recommendations for using echo to guide treatment

ASE, echocardiography, hypertension, document, EACVI, JASE, Thomas H. Marwick

July 7, 2015 – A new document from the American Society of Echocardiography (ASE) provides detailed guidance for clinicians on how to use echocardiography to see the full picture of the condition of patients with hypertension. The paper, Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE) is a joint project between ASE and the European Association of Cardiovascular Imaging (EACVI) and will appear in the July issue of the Journal of the American Society of Echocardiography (JASE).

Hypertension, or high blood pressure, is one of the leading risk factors for death globally, leading to a wide variety of cardiovascular problems, including coronary heart disease and stroke. While most of the general public are familiar with the traditional method of measuring blood pressure, systolic pressure over diastolic pressure, those numbers alone do not offer much information to physicians about the actual damage that may be occurring within a patient's cardiovascular system. 

Thomas H. Marwick, MBBS, Ph.D., of the Menzies Research Institute in Australia, commented, "While the primary goal of treatment is to reduce blood pressure to goal, echocardiographic measures of changes to the left ventricle (LV), for instance, can help predict prognosis. This is the first international recommendation on how to use echocardiography in this patient population."

The majority of the document outlines in detail the pathophysiology of cardiac responses to hypertension, which echocardiographic measures are most significant, and how to perform them most accurately.  "More research is still needed to show how clinicians can fully use the valuable information provided by echo to guide therapy and other clinical decisions," Marwick noted. "In the meantime, this paper represents a comprehensive guide on when, why, and how to gather the images and data that may influence clinician decision-making."

For more information: www.asecho.org

Related Content

American Heart Association Announces New Hypertension Center Certification
News | Hypertension | July 05, 2018
Physician practices now have access to new resources to improve their standard of quality care for hypertension...
YMCA and American Heart Association Partner to Improve Blood Pressure Control
News | Hypertension | April 05, 2018
YMCA of the USA (Y-USA) and the American Heart Association (AHA) are combining efforts to help more people better...
Higi Implementing New ACC/AHA Blood Pressure Guidelines at 11,000 North American Stations
News | Hypertension | March 28, 2018
Population health enablement company Higi announced their commitment to implement the 2017 American College of...
Petaluma Health Center Wins 2017 HIMSS Davies Award for Hypertension Control Program
News | Hypertension | February 16, 2018
February 16, 2018 — California’s Petaluma Health Center (PHC) was recently awarded a 2017 Healthcare Information and
SPRINT Trial Data Support New AHA/ACC Hypertension Guidelines
News | Hypertension | November 16, 2017
Findings from a landmark study funded by the National Institutes of Health (NIH) support a key component of the new...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension | September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Text Messaging Could Help Tackle High Blood Pressure in At-Risk Patients

Image courtesy of Michigan Medicine

News | Hypertension | September 06, 2017
A new National Institutes of Health-funded hypertension trial will examine the possibility of using an emergency...
MobiusHD Device Shows Promise in Treatment of Resistant Hypertension
News | Hypertension | August 30, 2017
Vascular Dynamics Inc. announced interim results of the company’s first-in-human trial of its MobiusHD implant...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension | August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Bayer Now Enrolling Patients for Global Pulmonary Arterial Hypertension Study
News | Hypertension | July 05, 2017
Bayer has enrolled the first patient in a global Phase IV study assessing the clinical effects of riociguat in patients...
Overlay Init